Maris Hartmanis

Member of the Board of Directors

Finansinspektionen (Sweden) Files from Sweden

Compiled from cited public records — every figure names the disclosure it came from, none copied from any wealth ranking. How we calculate this.

Positions on file
1
positions reconstructed from transactions reported to Finansinspektionen (FI) in Sweden

Not measurable for this profile: Reconstructed positions · 1-day change

Trading activity Sep 27, 2017 – Nov 29, 2024

Maris Hartmanis reported 16 transactions between Sep 27, 2017 and Nov 29, 2024. The buy and sell totals below count only codes SACQ, SDIS.

Open-market buys (SACQ)
281.0K SEK
5 purchases on file priced rows only
Open-market sales (SDIS)
3.1K SEK
3 sales on file priced rows only
All reported transactions
16
every code, including awards and exercises
Pattern
No transaction in the final 12 months of the window
last 12 months of the window

Reported transactions

Price 0.00 is a real reported figure on allotments, gifts and option exercises — not a missing number. The 16 most recent rows are grouped into 14 lines by date, company and transaction type — open a line to see every lot with its own source link.

How to read this list

Every row is one insider transaction as reported to FI, with a link back to the FI register filtered to that issuer and publication date. FI publishes no per-report permalink, so the link is a search, not a document. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. XSpray Pharma AB (publ) SSUB Subscriptionnot a buy/sell decision 2,500 shares 100.0K SEK at 40.00 SEK FI filing ↗
  2. XSpray Pharma AB (publ) SDIS Disposal 13,159 shares 2.6K SEK at 0.20 SEK FI filing ↗
  3. XSpray Pharma AB (publ) SEXI Exercise increasenot a buy/sell decision 2,385 shares 95.4K SEK at 40.00 SEK FI filing ↗
  4. XSpray Pharma AB (publ) SEXD Exercise decreasenot a buy/sell decisionreported at zero 2,385 shares 0 SEK at 0.00 SEK FI filing ↗
  5. XSpray Pharma AB (publ) SEXI Exercise increasenot a buy/sell decision 2,385 shares 95.4K SEK at 40.00 SEK FI filing ↗
  6. XSpray Pharma AB (publ) SEXD Exercise decreasenot a buy/sell decisionreported at zero 2,385 shares 0 SEK at 0.00 SEK FI filing ↗
  7. XSpray Pharma AB (publ) SSUB Subscriptionnot a buy/sell decision 2,385 shares 190.8K SEK at 80.00 SEK FI filing ↗
  8. XSpray Pharma AB (publ) SDIS Disposal 14,309 shares 429 SEK at 0.03 SEK FI filing ↗
  9. Xbrane Biopharma AB SSUB Subscription × 2not a buy/sell decision 2,139 shares 71.7K SEK
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    453 33.50 SEK 15.2K SEK FI filing ↗
    1,686 33.50 SEK 56.5K SEK FI filing ↗
  10. Xbrane Biopharma AB SACQ Acquisition 157 shares 4.7K SEK at 30.00 SEK FI filing ↗
  11. Xbrane Biopharma AB SACQ Acquisition 2,343 shares 70.3K SEK at 30.00 SEK FI filing ↗
  12. Xbrane Biopharma AB SACQ Acquisition × 2 3,750 shares 104.8K SEK
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    1,500 61.04 SEK 91.6K SEK FI filing ↗
    2,250 5.88 SEK 13.2K SEK FI filing ↗
  13. XSpray Pharma AB (publ) SDIS Disposalreported at zero 2,475 shares 0 SEK at 0.00 SEK FI filing ↗
  14. XSpray Pharma AB (publ) SACQ Acquisition 4,600 shares 101.2K SEK at 22.00 SEK FI filing ↗

Reconstructed positions

Reconstructed by adding up every transaction this person reported to FI since 2016. FI publishes transactions, not balances, so this is a computed figure, not a disclosed one — and it omits anything held before the register began.

What is not counted here

Each row comes from a public disclosure named on this page. Private companies, real estate, bonds and crypto are not in those disclosures and are therefore not counted here. Shares held through a holding company are recorded against that company, not against the individual behind it.

Equity positions reported to Finansinspektionen (FI) in Sweden, with the disclosure date shown on each row.
Issuer ISIN Security Shares Price Value Form Reported Filing
Xbrane Biopharma AB SE0007789409 Xbrane Biopharma AB 6,139 FI marknadssok.fi.se ↗

Other shareholders on record at the same companies

People who also appear on the shareholder record of a company where Maris Hartmanis reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

Every figure on this page is quoted from the public record named beside it, with the date it was true. Nothing here is our own calculation.

Think a number here is wrong? Check the named disclosure and its date against the tables above — how to report it.

Profile record last refreshed Sep 14, 2026.